Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects
Peipei Song(The University of Tokyo), Wei Tang(National Center for Global Health and Medicine), Kuansheng Ma(Army Medical University), Norihiro Kokudo(National Center for Global Health and Medicine), Qiang Li(Chinese Academy of Sciences), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), Kiyoshi Hasegawa(Bunkyo University), Shuguo Zheng(Army Medical University), Ti Zhang(Zhejiang Chinese Medical University), Zhigang Wang(Chongqing Medical University), Xin Zhao(Soochow University), Qiang Wu(Macau University of Science and Technology), Yoshinori Inagaki(Yokohama University of Pharmacy), Xiaobin Feng(Army Medical University), Dalu Kong(Tianjin Medical University Cancer Institute and Hospital), Keming Zhang(Second Military Medical University), Yasuhiko Sugawara(Kumamoto University)
Cited by 47
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780